CIK 0001635077
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473324725
- Phone
- +1 833-275-2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-13 | Bond Ryan Director | Purchase | +21,122 | $2.37 | $50K | 76,122 |
| 2026-06-11 | Bond Ryan Chief Strategy Officer | Grant or award | +55,000 | 55,000 | ||
| 2022-04-22 | Bond Ryan Chief Strategy Officer | Purchase | +20,000 | $2.80 | $56K | 20,000 |
| 2022-04-22 | Bond Ryan Chief Strategy Officer | Purchase · Warrants for Common Stock (right to buy) | +21,000 | $0.73 | $15K | 48,527 |
Page 1 of 1 · 4 trades